EFFECT OF INTERLEUKIN-4 AND INTERLEUKIN-10 ON LEUKOCYTE MIGRATION AND NITRIC-OXIDE PRODUCTION IN THE MOUSE

被引:68
作者
PERRETTI, M
SZABO, C
THIEMERMANN, C
机构
[1] UNIV LONDON ST BARTHOLOMEWS HOSP & MED COLL,WILLIAM HARVEY RES INST,DEPT CARDIOVASC PHARMACOL,LONDON EC1M 6BQ,ENGLAND
[2] UNIV LONDON ST BARTHOLOMEWS HOSP & MED COLL,WILLIAM HARVEY RES INST,DEPT BIOCHEM PHARMACOL,LONDON EC1M 6BQ,ENGLAND
关键词
INFLAMMATION; NEUTROPHILS; CD11B; INTERLEUKIN-1; INTERLEUKIN-8; NITRIC OXIDE SYNTHASE;
D O I
10.1111/j.1476-5381.1995.tb15061.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effect of systemic treatment of mice with murine recombinant interleukin-4 (IL-4) or interleukin-10 (IL-10) on neutrophil infiltration into a specific tissue site and nitric oxide (NO) production from peritoneal macrophages was investigated. 2 2 Intravenously (i.v.) administered IL-4 (0.01-10 mu g per mouse, approximately 0.3-300 mu g kg(-1), i.v.) and IL-10 (0.01-1 mu g per mouse, approximately 0.3-30 mu g kg(-1), i.v.) dose-dependently inhibited neutrophil accumulation into a 6-day-old murine air-pouch induced by local application of interleukin-1 beta (IL-1 beta, 5 ng), with approximate ED(50)s of 0.35 and 0.90 mu g, respectively. Neither IL-4 (1 mu g, 30 mu g kg(-1), i.v.) nor IL-10 (1 mu g, 30 mu g kg(-1), i.v.) prevented leucocyte accumulation in the mouse air-pouches when interleukin-8 (IL-8, 1 mu g) was used as chemoattractant. Similarly, neither cytokine had any effect on the in vitro up-regulation of CD11b antigen on the surface of murine circulating neutrophils. 3 Treatment of mice with lipopolysaccharide (LPS, 0.3 mg kg(-1), i.p.) caused an increase in the formation of NO (measured as nitrite accumulation) in the supernatant of peritoneal macrophages ex vivo. Pretreatment of mice with IL-4 (0.01-1 mu g i.v., 20 min before LPS), but not with IL-10 (1 mu g i.v., 20 min before LPS), caused a dose-dependent reduction in this LPS-stimulated formation of nitrite by peritoneal macrophages ex vivo. 4 Activation of murine macrophages with LPS (1 mu g ml(-1) for 24 h) in vitro caused a significant increase in nitrite release in the supernatant of these cells. Pretreatment of either J774.2 or peritoneal macrophages with IL-4 (0.1-1 mu g ml(-1), 20 min before LPS), but not with IL-IO (1 mu g ml(-1), 20 min before LPS) caused a concentration-related attenuation of this LPS-stimulated nitrite formation. 5 Thus, both IL-4 and IL-10 inhibit the migration of leucocytes (stimulated by IL-1 beta) in vivo; IL-4 (but not IL-10) inhibits the induction of NO synthase caused by LPS in murine macrophages in vitro and ex vivo.
引用
收藏
页码:2251 / 2257
页数:7
相关论文
共 42 条
[1]   MECHANISM OF SUPPRESSION OF NITRIC-OXIDE SYNTHASE EXPRESSION BY INTERLEUKIN-4 IN PRIMARY MOUSE MACROPHAGES [J].
BOGDAN, C ;
VODOVOTZ, Y ;
PAIK, J ;
XIE, QW ;
NATHAN, C .
JOURNAL OF LEUKOCYTE BIOLOGY, 1994, 55 (02) :227-233
[2]  
BRODDUS VC, 1994, J IMMUNOL, V152, P2960
[3]   INTERLEUKIN-10 (IL-10) INHIBITS THE RELEASE OF PROINFLAMMATORY CYTOKINES FROM HUMAN POLYMORPHONUCLEAR LEUKOCYTES - EVIDENCE FOR AN AUTOCRINE ROLE OF TUMOR-NECROSIS-FACTOR AND IL-1-BETA IN MEDIATING THE PRODUCTION OF IL-8 TRIGGERED BY LIPOPOLYSACCHARIDE [J].
CASSATELLA, MA ;
MEDA, L ;
BONORA, S ;
CESKA, M ;
CONSTANTIN, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2207-2211
[4]  
CASSATELLA MA, 1994, J EXP MED, V179, P1395
[5]   REGULATION OF INDUCIBLE NITRIC-OXIDE SYNTHASE MESSENGER-RNA LEVELS BY LPS, INF-GAMMA, TGF-BETA, AND IL-10 IN MURINE MACROPHAGE CELL-LINES AND RAT PERITONEAL-MACROPHAGES [J].
CHESROWN, SE ;
MONNIER, J ;
VISNER, G ;
NICK, HS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 200 (01) :126-134
[6]   INDUCTION OF MACROPHAGE NITRIC-OXIDE PRODUCTION BY INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA IS ENHANCED BY INTERLEUKIN-10 [J].
CORRADIN, SB ;
FASEL, N ;
BUCHMULLERROUILLER, Y ;
RANSIJN, A ;
SMITH, J ;
MAUEL, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (08) :2045-2048
[7]  
CUNHA FQ, 1994, IMMUNOLOGY, V81, P211
[8]  
DEWAALMALEFYT R, 1991, J EXP MED, V174, P1209
[9]  
DINARELLO CA, 1991, BLOOD, V77, P1627
[10]  
DONNELLY RP, 1993, J IMMUNOL, V151, P5603